000 01299 a2200337 4500
005 20250515181825.0
264 0 _c20100405
008 201004s 0 0 eng d
022 _a2040-2066
024 7 _a10.1177/095632020901900602
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avon Eije, Karin J
245 0 0 _aRNA-interference-based gene therapy approaches to HIV type-1 treatment: tackling the hurdles from bench to bedside.
_h[electronic resource]
260 _bAntiviral chemistry & chemotherapy
_c2009
300 _a221-33 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aBase Sequence
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
650 0 4 _aGenetic Therapy
_xadverse effects
650 0 4 _aGenetic Vectors
_xadverse effects
650 0 4 _aHIV Infections
_xtherapy
650 0 4 _aHIV-1
_xgenetics
650 0 4 _aHumans
650 0 4 _aRNA Interference
650 0 4 _aRNA, Small Interfering
_xadverse effects
650 0 4 _aTranslational Research, Biomedical
700 1 _aBerkhout, Ben
773 0 _tAntiviral chemistry & chemotherapy
_gvol. 19
_gno. 6
_gp. 221-33
856 4 0 _uhttps://doi.org/10.1177/095632020901900602
_zAvailable from publisher's website
999 _c19048941
_d19048941